Today's guest is Symphony AI CEO Sanjay Dhawan. Sanjay took the helm of Symphony last year after leading the automotive AI firm Cerence since 2019. On the AI in Business podcast, Sanjay discusses insights on using highly defined business outcomes to frame up how fast to scale enterprise data strategies, citing examples in banking and CPG. Together with Emerj CEO Daniel Faggella, Sanjay also dissects the different ways the workflows therein can change for startups and legacy enterprises so that each can judge whether a deployment is right for them. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

Follow These Steps Before Deploying Enterprise AI - with SymphonyAI CEO Sanjay Dhawan

The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI.

Each week, Emerj Artificial Intelligence Research CEO Daniel Faggella interviews top AI executives from Fortune 500 firms and unicorn startups - to uncover trends, use-cases, and best practices for practical AI adoption.

Subscribe to Emerj's weekly AI newsletter by downloading our "Beginning with AI" PDF guide: https://emerj.com/beg1

Technology

Tech News

Podcasting

Gadgets

Software How-To

Business

Investing

Careers

Management & Marketing

Business News

Shopping

Management

Today’s guest is Chris Helsel, Senior Vice President of Global Operations and Chief Technology Officer at The Goodyear Tire & Rubber Company. Despite the disparity in the predictions about self-driving cars that were made a decade ago, the era of automated transportation is close at hand. Chris joins the podcast today to discuss the enormous implications of the transition for numerous industries, from consumer goods to manufacturing and retail, and every industry that touches on transportation. To access Emerj’s frameworks for AI readiness, ROI, and strategy, visit Emerj Plus at emerj.com/p1.

Tires and Data Collection for Autonomous Vehicles - with Chris Helsel of Goodyear

Today’s guest is Dr. John Almasan, Head of AI & Emerging Technologies at TIAA. TIAA, or the Teachers Insurance and Annuity Association of America-College Retirement Equities Fund, is a US-based insurance provider specializing in retirement services in areas like academia, research, healthcare, and government. Dr. Almasan joins Emerj CEO and Head of Research Daniel Faggella on today’s podcast to discuss AI in insurance with a focus on governance, talent, and innovation. Together, they cover practical use cases in customer experience, fraud detection, and marketing throughout the episode. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

GenAI for CX, Cybersecurity, Fraud Detection, and Marketing Workflows in Insurance - with Dr. John Almasan of TIAA

Today’s guest is Shreyas Becker, Head of AI & Data Products, Manufacturing & Supply at Sanofi. Shreyas joins Emerj Senior Editor Matthew DeMello on today’s podcast to talk about alleviating pain points for supply chain leaders in life sciences spaces. From building systems that deliver “real world evidence” to the subject matter experts and managers who need it to the pros and cons of sharing sensorial data with big tech data storage platforms like Amazon Web Services – Shreyas helps the executive podcast audience understand how problems are both viewed and solved through the lens of data, from no matter where they arise. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

AI for Supply Chain Challenges in Life Sciences - with Shreyas Becker of Sanofi

Today’s guest is Daniel Ferrante, AI Leader in R&D; and Data Strategy at Deloitte. Together with Emerj CEO and Head of Research Daniel Faggella, they delve into the complex challenges in AI adoption that major pharmaceutical firms encounter with cultural shifts, technological complexities, and the difficulties in monetizing data and aligning teams efficiently. Additionally, the pair explores the future landscape of phenotypical drug discovery, drawing insights from the context of COVID-19. Their focus underscores the critical importance of collecting and analyzing data to yield actionable insights, especially in the healthcare sector and amidst global health crises. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Overcoming Cultural and Technological Hurdles for AI Integration in Life Sciences - with Daniel Ferrante of Deloitte

Today’s guest is Bikalpa Neupane, Head of AI/GenAI and Natural Language Processing at Takeda. Bikalpa returns to the program to talk about the difference between a legacy enterprise culture and a data-based enterprise culture, showing how legacy leaders in sectors as diverse as healthcare, financial services, manufacturing, and beyond can make the transition in today’s AI-driven global economy along the way. Later, he and Emerj Senior Editor Matthew DeMello pull apart challenges for large enterprises as more open-source AI tools become available to individuals, eroding the traditional and structural advantages legacy firms have long held in the marketplace. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Follow These Steps Before Deploying Enterprise AI - with SymphonyAI CEO Sanjay Dhawan

Download our free app to listen on your phone